Universidad Católica San Antonio de Murcia
Murcia, 30107, Spain
Location status: Recruiting
NCT Number: NCT07437222
Randomized, double-blind, parallel, placebo-controlled clinical trial designed and conducted to evaluate the effect of daily consumption of ginger, on parameters related to inflammation, oxidative stress, and endothelial damage in adults with excess adiposity.
Interested in participating?
Request Info23 year–65 year
All sexes
Interventional
Not applicable
Murcia, 30107, Spain
Location status: Recruiting
The duration of the study will be 60 days, during which the investigational product or placebo will be consumed daily according to the assigned intervention. Participants will be randomly allocated to the different study arms following a double-blind design.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Daily consumption of ginger capsules for 60 days. Each capsule contains 500 mg of ginger extract. Participants will be instructed to take two capsules per day.
Placebo capsules without ginger. The capsules do not contain ginger or any active bioactive compounds. Participants will be instructed to take two capsules per day.
Time frame: Day 1 and Day 60
Evaluation on differences in serum IL-1β levels
Time frame: Day 1 and Day 60
Evaluation on differences in serum IL-6 levels
Time frame: Day 1 and Day 60
Evaluation on differences in homocysteine levels
Time frame: Day 1 and Day 60
Evaluation on differences in fibrinogen concentrations
Time frame: Day 1 and Day 60
Evaluation on differences in atherogenic index
Time frame: Day 1 and Day 60
Evaluation on differences in total cholesterol leveles (mg/dL)
Time frame: Day 1 and Day 60
Evaluation on differences in LDL-cholesterol (mg/dL) levels
Time frame: Day 1 and Day 60
Evaluation on differences in HDL-cholesterol (mg/dL) levels
Time frame: Day 1 and Day 60
Evaluation on differences in triglycerides (mg/dL) levels
Time frame: Day 1 and Day 60
Evaluation on differences in fasting plasma glucosa (mg/dL) levels
Time frame: Day 1 and Day 60
Evaluation of differences in body weight (kg)
Time frame: Day 1 and Day 60
BMI will be calculated from measured weight and height using the formula weight (kg) / height² (m²).
Time frame: Day 1 and Day 60
Evaluation of differences in fat mass (%)
Time frame: Day 1 and Day 60
Evaluation of differences in lean mass (%)
Time frame: Day 1 and Day 60
Measured as changes in systolic and diastolic blood pressure (mmHg)
Contact information is provided by the study sponsor or research team.
Ana Mª Garcia Munoz
Other
Study of the Effect of Ginger Capsules on Markers of Inflammation, Oxidative Stress, and Endothelial Damage
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07433998
Cardiometabolic Risk Factors, Inflammation Biomarkers
Murcia, Spain
View Trial DetailsNCT06983145
Inflammation, Inflammation Biomarkers
Myrina, Limnos, Greece
View Trial DetailsNCT06769035
Body Weight, Inflammation
Guadalajara, Jalisco, Mexico
View Trial DetailsNCT07729930
Arthralgia, Blood Pressure and Augmentation Index
Loughborough, United Kingdom
View Trial Details